CytomX Therapeutics, Inc. - COM (CTMX)

Q2 2021 13F Holders as of 6/30/2021

Type / Class
Equity / COM
Number of holders
119
Total Shares
56.7M
Shares change
+2.11M
Total reported value, excl. options
$359M
Value change
+$4.31M
Put/Call ratio
2.43
Number of buys
67
Number of sells
-50
Price
$6.33
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.